Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

G. B. Mills, R. Schmandt, D. Gershenson, R. C. Bast

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	2286-2288
Number of pages	3
Journal	Clinical Cancer Research
Volume	5
Issue number	9
State	Published - Sep 28 1999
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Other files and links

Cite this

@article{a0f97c3106d049dabc9950570861f632,

title = "Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?",

author = "Mills, {G. B.} and R. Schmandt and D. Gershenson and Bast, {R. C.}",

year = "1999",

month = sep,

day = "28",

language = "English (US)",

volume = "5",

pages = "2286--2288",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "9",

}

TY - JOUR

T1 - Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

AU - Mills, G. B.

AU - Schmandt, R.

AU - Gershenson, D.

AU - Bast, R. C.

PY - 1999/9/28

Y1 - 1999/9/28

UR - http://www.scopus.com/inward/record.url?scp=0032882879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032882879&partnerID=8YFLogxK

M3 - Editorial

C2 - 10499594

AN - SCOPUS:0032882879

SN - 1078-0432

VL - 5

SP - 2286

EP - 2288

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 9

ER -